contact us

Baxter logo

       

Baxter's Latin America and Canada region employs more than 7,000 people in 17 countries and is headquartered in Fort Lauderdale, Florida. The company’s sales in Latin America and Canada were approximately $1.5 billion in 2010.

Baxter's presence in Latin America and Canada is divided into six areas:

Manufacturing Facilities
Businesses in Latina America
Businesses in Canada
In The Community

on top arrow

Manufacturing Facilities

Baxter has eleven manufacturing facilities in the Latin America and Canada region.  They are located in:

Baxter’s plants in Cuernavaca, Cali and Sao Paulo are fully integrated plants that manufacture a range of peritoneal dialysis (PD) and intravenous (IV) solutions for local use and export. Sao Paulo also manufactures IV administration sets and provides contract manufacturing services for local and international healthcare and animal health companies. 

The Cali and Atlacomulco plants manufacture renal and IV administration sets. In addition, Atlacomulco manufactures sterile injectable water ampoules and provides contract manufacturing services for local and international healthcare companies.  Baxter’s plants in Costa Rica and Puerto Rico produce a range of medication delivery products for export to the United States and around the world.

Canada’s Alliston, Ontario plant manufactures IV, nutrition, PD and hemodialysis (HD) solutions, 99 percent of which are sold in Canada. It is the longest standing parental solutions plant in Canada and the only Canadian manufacturer of PD solutions. The Sherbrooke, Quebec plant produces IV administration sets for the Canadian market.
 manufacturing services for local and international healthcare companies. Baxter's plants in Costa Rica and Puerto Rico produce medication delivery products for export to the United States and around the world.

on top arrow

Businesses in Latina America

Baxter's Medical Products business is the company’s largest business in Latin America in terms of sales. It is committed to growing the use of home dialysis therapies, given the clinical and quality-of-life benefits these therapies offer patients, as well as the potential economic benefits they can provide governments and healthcare providers. Baxter also provides dialysis services in countries such as Colombia, Guatemala, Ecuador and Argentina. Through these dialysis centers, Baxter provides PD, HD, pre-dialysis patient management and education, follow-up treatment for transplant patients and acute dialysis services.

The Medical Products business is also one of the largest suppliers of IV solutions in flexible plastic containers in Latin America, producing more than 200 million units a year. Over the past seven years, Baxter has been educating clinicians on the benefits of “closed” versus “open” IV systems. Closed systems do not allow external air to get into a solution, which can reduce bloodstream infections, mortality rates and total healthcare costs.  An increasing number of hospitals in Latin America have been converting to closed systems.
Baxter also offers premixed drugs in flexible containers and ready-to-use parenteral nutrition solutions across the region (Puerto Rico offers custom parental nutrition products through its own compounding pharmacy). In addition, Baxter provides anesthetic gases for general anesthesia, which are manufactured at the company’s Guayama, Puerto Rico, facility, and is the only company in Latin America that offers customers all three modern inhaled anesthetics.

Baxter’s Bioscience business sells recombinant and plasma-derived factor VIII therapy for hemophilia, plasma-derived biotherapeutics for conditions such as primary immunodeficiency and biosurgery products. Baxter provides all of these products in Latin America, and was the first company to introduce a recombinant factor VIII concentrate for the treatment of hemophilia in the region.

Baxter also operates a service center in Costa Rica that manages financial activities for the company’s operations in the United States and Puerto Rico.

on top arrow

Businesses in Canada

In Canada, Baxter's BioScience business is a leader in recombinant and plasma-derived therapies to treat hemophilia and other bleeding disorders; plasma-derived biotherapeutics to treat immunodeficiency, burns and shock, and other blood-related conditions; biosurgery wound-sealing products and vaccines.

The Medical Products business is a leading manufacturer of products used in the delivery of fluids and drugs to patients. These include IV solutions and needleless administration sets, premixed drugs and drug-reconstitution systems, nutrition products, oncolytics, infusion pumps and inhaled anesthetics. This business is also a leader in home dialysis therapies for patients with end-stage renal disease, manufacturing products for HD and PD, including PD solutions, automated cyclers and clinical software.

In 1986, Baxter opened the first outsourced hospital admixing service in Canada. Featuring state-of-the-art quality control processes and clean room technology, Baxter’s Central Intravenous Admixture (CIVA) pharmacy service provides Canadian hospital pharmacists and healthcare professionals with parenteral therapies prepared using aseptic techniques. Baxter’s CIVA Pharmacy Services provides a range of ready-to-use intravenous admixtures that encompasses oncology, anti-infectives, analgesics, nutrition, critical care and cardiology. 
Baxter’s 11,500-square-foot Canadian Technical Services depot, located in Mississauga, provides Canadian hospital customers, healthcare professionals and home patients with equipment repairs, technical training, service contract management, parts ordering and other post-sales equipment support.

on top arrow

In the Community

In Baxter also is committed to making a positive impact in its communities through a variety of charitable giving activities. 
 
In 2010, the combined charitable giving from Baxter and The Baxter International Foundation, the philanthropic arm of Baxter, totaled nearly $80 million, with more than $48 million from product donations through donor partners and the company’s U.S. patient assistance programs. In Latin America and Canada, the Foundation awarded more than $837,000 in grants and scholarships to support healthcare access and community projects. In addition, the region received more than $11 million in donated product for critical local needs.

Baxter employees in Latin America and Canada also take an active role in their communities. In 2010, Baxter employees around the world logged 163,000 volunteer hours as part of the company’s Global Service Project. In Latin America and Canada, employees recorded more than 17,000 hours in the community through various volunteer initiatives.

on top arrow